Exosens Soars 4.25% Following Record 5G Intensifier Tube Order
Exosens climbed 4.25% on Monday, January 12, after announcing a record order of over 7,000 5G light intensifier tubes from ACTinBlack Group, scheduled for delivery between 2027 and 2028. This order represents the largest single contract for 5G tubes secured by the group to date.
Significant Market Response to Major Order
Exosens shares rose 4.25% on the morning of Monday, January 12, 2026, reaching 58.90 euros from 56.50 euros at last Friday's close. The increase followed the announcement of a major order of more than 7,000 fifth-generation light intensifier tubes from ACTinBlack Group, a European manufacturer of night vision systems, with delivery planned between 2027 and 2028. This is the largest single order of 5G tubes won by the group so far, confirming the rapid market adoption of this new technology. The 5G tubes, which were officially launched just a few months ago, provide a 30% improvement in overall performance and up to a 35% increase in detection ranges compared to current standard intensifier tubes, according to the group. This order comes amid favorable circumstances for Exosens, which has shown a weekly performance of 17.8% and a three-month increase of 35.56%. Over the past year, the stock has even seen a spectacular rise of 162.9%, reflecting the positive momentum of the French technology specialist in amplification and detection.
Technical Breakthrough and Market Outlook
From a technical standpoint, the price of 58.90 euros is now above the resistance level of 56.50 euros, indicating a significant bullish breakout. The stock is performing well above its moving averages, with a 50-day moving average at 46.71 euros and a 200-day moving average at 41.79 euros, confirming a clearly upward trend. However, the RSI has reached 88, placing the stock in a pronounced overbought zone, which suggests a possible short-term consolidation phase after this bullish sequence. This performance is supported by a solid order book and the ramping up of 5G technology. As a strategic supplier to NATO for night vision technologies, Exosens continues to play a key role in enhancing operational readiness and contributes to defense sovereignty with innovations dedicated to armed forces. The group, which employs over 2,000 people across 12 sites in Europe and North America, projects a 2025 revenue growth in the upper range of 15 to 20% and an adjusted EBITDA growth in the lower range of 20 to 25%.
